SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: FEBRUARY 27, 2002 DATE OF EARLIEST EVENT REPORTED: FEBRUARY 27, 2002 ICN PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) DELAWARE 1-11397 33-0628076 (State or other (Commission File (I.R.S. Employer jurisdiction of number) Identification Number) incorporation or organization) 3300 HYLAND AVENUE COSTA MESA, CALIFORNIA 92626 (Address of principal executive offices) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (714) 545-0100 Item 5. Other Events. ------------ On February 27, 2002, the registrant issued the press release filed as Exhibit 99.1 hereto. Item 7. Financial Statements and Exhibits. --------------------------------- Exhibit Description ------- ----------- 99.1 Press Release issued February 27, 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on behalf of the undersigned hereunto duly authorized. Dated: February 27, 2002 ICN PHARMACEUTICALS, INC. By: /s/ Gregory Keever ------------------------------ Gregory Keever Executive Vice President, General Counsel and Corporate Secretary EXHIBIT INDEX Exhibit Description ------- ----------- 99.1 Press Release issued February 27, 2002.